Sunday, April 16, 2017 7:01:30 PM
On that note, I think investor sentiment is turning around some. We got a partner for XCede to start the pre-clinicals, so positive progress will add value to biomedical and imo share price. Optics is growing. and current administration looks to be interested in increasing defense spending, which is good for RMD. Also, one of Sulick's CC responses seemed to allude that the major holders may be open to selling parts of the company since they own almost half of DYSL and are getting old. He said the board would meet in May, so who knows we may see a buyout or partial asset sale down the road.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM